All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| FSTX / F-star Therapeutics Inc
|
|
|
|
|
|
|
|
| FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| US92731L1145 / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| KYG9127T1242 / WARRANTS
|
|
|
|
|
|
|
|
| PRDS / Pardes Biosciences Inc
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| / Pebblebrook Hotel Trust
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
| LOGC / ContextLogic Holdings Inc.
|
|
|
|
|
|
|
|
| NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
| ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
| TBIO / Telesis Bio, Inc.
|
|
|
|
|
|
|
|
| VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
|
|
|
|
|
|
|
|
| ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
| TMPMU / Turmeric Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| AKUS / Akouos Inc
|
|
|
|
|
|
|
|
| BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| CMAX / CareMax, Inc.
|
|
|
|
|
|
|
|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
| TMPM / Turmeric Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| CDAK / Codiak Biosciences Inc
|
|
|
|
|
|
|
|
| SBTX / Silverback Therapeutics Inc
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| EUCR / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
| RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
| JYAC / Jiya Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc. Call
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| KNTE / Kinnate Biopharma Inc.
|
|
|
|
|
|
|
|
| AMTI / Applied Molecular Transport Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc. Call
|
|
|
|
|
|
|
|
| OMEG / Omega Alpha SPAC - Class A
|
|
|
|
|
|
|
|
| HLXA / Helix Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
| BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
| NGM / NGM Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| STTK / Shattuck Labs, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| CYCN / Cyclerion Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AADI / Aadi Bioscience, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SURF / Surface Oncology Inc
|
|
|
|
|
|
|
|
| GRTS / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
| ACIU / AC Immune SA
|
|
|
|
|
|
|
|
| PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
| EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
| ALVR / AlloVir, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc Call
|
|
|
|
|
|
|
|
